# PYRIDOSTIGMINE BROMIDE
> **ANDA203184** · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS INC · Approved 2015-09-15
## Drug
- **FDA Application Number:** ANDA203184
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PYRIDOSTIGMINE BROMIDE
- **Generic name:** Pyridostigmine Bromide
- **Active ingredients:** PYRIDOSTIGMINE BROMIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** IMPAX LABS INC
- **First approval:** 2015-09-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203184)
---
*AI Analytics · CC0 1.0*